Teresa Cunha-Oliveira started her scientific studies by completing the "Licenciatura" in Biochemistry from the University of Coimbra, Portugal, in 1999, with a thesis on Forensic Genetic Profiling. After that, in 2003 she completed her Masters Degree in Cell Biology, from the same University, where she started to be interested in the cellular mechanisms behind the neurotoxicity of drugs of abuse. In her PhD in Biology (Cell Biology) from the same University, obtained in 2007, she studied the involvement of mitochondria in the neuronal dysfunction induced by drugs of abuse. In her first post-doctoral period (2007-2010) in the Center for Neuroscience and Cell Biology (CNC, Coimbra), she was involved in a partnership with a Medicinal Chemistry group at the University of Porto to uncover the cellular effects of a newly found chemical interaction between heroin and cocaine (speedball). In her second post-doctoral period (2010-2012), she was focused on the role of mitochondria in Huntington's disease, a genetic neurodegenerative disease. From 2013 until now, she is part of the MitoXT group at the CNC, and her interests include: Screening of mitochondrial health biomarkers, Mitochondria-targeted therapeutic strategies, Mitochondrial dynamics and neurodegeneration, Mitochondrial bioenergetics in health and disease, Interplay between mitochondria and epigenetics.